RS20050049A - Composition containing an andogenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition - Google Patents

Composition containing an andogenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition

Info

Publication number
RS20050049A
RS20050049A YUP-2005/0049A YUP20050049A RS20050049A RS 20050049 A RS20050049 A RS 20050049A YU P20050049 A YUP20050049 A YU P20050049A RS 20050049 A RS20050049 A RS 20050049A
Authority
RS
Serbia
Prior art keywords
composition
andogenous
11beta
composition containing
male contraceptive
Prior art date
Application number
YUP-2005/0049A
Other languages
Serbian (sr)
Inventor
Reinhard Nubbemeyer
Ursula Friederike Habenicht
Rolf Bohlmann
Original Assignee
Schering Aktiengesellschaft,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft, filed Critical Schering Aktiengesellschaft,
Priority claimed from PCT/EP2003/008192 external-priority patent/WO2004011008A1/en
Publication of RS20050049A publication Critical patent/RS20050049A/en
Publication of RS50907B publication Critical patent/RS50907B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a novel chemical composition containing an androgenous 11ß-halogen steroid and the progestational hormone of formula (I), to a pharmaceutical composition containing said chemical composition and to a male contraceptive based on said pharmaceutical composition.
YUP-2005/0049A 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDOGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION RS50907B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10234525A DE10234525A1 (en) 2002-07-25 2002-07-25 New compositions, useful as male contraceptives, comprise synergistic active agent combination of androgenic 11beta-halo-steroid and gestagenic 14 alpha, 17alpha-ethylene-estratrienone derivative
US44940003P 2003-02-25 2003-02-25
PCT/EP2003/008192 WO2004011008A1 (en) 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Publications (2)

Publication Number Publication Date
RS20050049A true RS20050049A (en) 2007-09-21
RS50907B RS50907B (en) 2010-08-31

Family

ID=30010499

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0049A RS50907B (en) 2002-07-25 2003-07-25 COMPOSITION CONTAINING AN ANDOGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Country Status (9)

Country Link
AR (1) AR040691A1 (en)
CO (1) CO5690601A2 (en)
DE (1) DE10234525A1 (en)
EA (1) EA007601B1 (en)
ME (1) MEP38208A (en)
NO (1) NO20050995L (en)
RS (1) RS50907B (en)
UA (1) UA78834C2 (en)
ZA (1) ZA200501653B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714965A1 (en) * 1987-04-30 1988-11-10 Schering Ag 3-METHYLENE-4-ANDROSTEN-17-ONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE19650352A1 (en) * 1996-12-04 1998-07-30 Jenapharm Gmbh New male oral contraceptive composition
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
DE19848303A1 (en) * 1998-10-14 2000-04-20 Schering Ag Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
AU2001230447A1 (en) * 2000-02-15 2001-08-27 Schering Ag Male contraceptive formulation comprising norethisterone
EP1216699A1 (en) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermal system comprising a highly potent progestin
DE10104327A1 (en) * 2001-01-24 2002-07-25 Schering Ag New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control

Also Published As

Publication number Publication date
ZA200501653B (en) 2007-11-28
UA78834C2 (en) 2007-04-25
DE10234525A1 (en) 2004-02-05
EA007601B1 (en) 2006-12-29
AR040691A1 (en) 2005-04-13
MEP38208A (en) 2011-02-10
CO5690601A2 (en) 2006-10-31
NO20050995L (en) 2005-04-25
RS50907B (en) 2010-08-31
EA200500222A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
IL166432A0 (en) Composition containing an androgenous 11?-halogen steroid and a progestational hormone and male contraceptive based on said composition
HK1078588A1 (en) Process to prepare eplerenone
EE05282B1 (en) ™ strogen-ts compositions of clodextrin complexes
MXPA05001061A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions.
RS97604A (en) New etonogestrel esters
AU2003255355A1 (en) Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
DK1409021T3 (en) Formulation comprising fulvestrant
DE60201074D1 (en) Pyrazolopyridinderivate
RS20050049A (en) Composition containing an andogenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
TW200630109A (en) Drug for external use and adhesive patch
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
SI1635843T1 (en) Therapy comprising dienogest for hormone replacement and depression
AU2003282868A1 (en) Crystalline 17beta-hydroxy-7alpha- (5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone
GB0128071D0 (en) Medicament
WO1996028154A3 (en) Use of anti-oestrogens as male contraceptives
AU2002326391A1 (en) Carvedilol polymorph
DK1365768T3 (en) Use of ER beta-selective antagonists as contraception.
WO2003040316A3 (en) Selective elimination of cd52+ cells and uses thereof
姚晶晶 et al. My Happiest Day
GB0205327D0 (en) compounds
WO2005046566A3 (en) Stable gabapentin containing composition
YU87302A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1